Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Evelo Biosciences, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 66 | 1 | 64 | −1 |
| Shares | 47.0M | 479.2K | 47.1M | +574.7K (+1.2%) |
| Value | $645.4M | $6.58M | $331.6M | −$307.2M (−48.1%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Evelo Biosciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Belvedere Trading LLC | 137,751 | $1.13M | 0.31% |
| Bessemer Group Inc | 61,289 | $431.0K | 0.00% |
| Gsa Capital Partners LLP | 11,624 | $82.0K | 0.01% |
| Jane Street Group, LLC | 11,266 | $79.0K | 0.00% |
| Invesco Ltd. | 10,877 | $77.0K | 0.00% |
| SG Americas Securities, LLC | 10,454 | $74.0K | 0.00% |
| State Board of Administration of Florida Retirement System | 10,241 | $72.0K | 0.00% |
| Cutler Group LP | 3,498 | $24.0K | 0.00% |
| Jefferies Group LLC | 33 | $232 | 0.00% |
Sold out (10)
Institutions that held Evelo Biosciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Alberta Investment Management Corp | 40,000 | $550.0K |
| D. E. Shaw & Co., Inc. | 33,774 | $464.0K |
| Amundi | 32,472 | $446.0K |
| Citadel Advisors LLC | 19,478 | $268.0K |
| MetLife Investment Management | 12,153 | $167.0K |
| Old Mission Capital LLC | 10,061 | $138.0K |
| Metropolitan Life Insurance Co | 8,937 | $122.8K |
| Dorsey Wright & Associates | 3,207 | $44.0K |
| Acadian Asset Management LLC | 1,550 | $21.0K |
| US Bancorp | 271 | $4.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Evelo Biosciences, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Mayo Clinic | 479,242 | $6.58M |